Literature DB >> 35098363

Generation of dystrophin short product-specific tag-insertion mouse: distinct Dp71 glycoprotein complexes at inhibitory postsynapse and glia limitans.

Takahiro Fujimoto1, Takeshi Yaoi1, Kenta Nakano2, Tetsuya Arai2, Tadashi Okamura2, Kyoko Itoh3.   

Abstract

Duchenne muscular dystrophy (DMD), the most severe form of dystrophinopathies, is a fatal X-linked recessive neuromuscular disorder characterized by progressive muscle degeneration and various extents of intellectual disabilities. Physiological and pathological roles of the responsible gene, dystrophin, in the brain remain elusive due to the presence of multiple dystrophin products, mainly full-length dystrophin, Dp427, and the short product, Dp71. In this study, we generated a Dp71-specific hemagglutinin (HA) peptide tag-insertion mice to enable specific detection of intrinsic Dp71 expression by anti-HA-tag antibodies. Immunohistochemical detections in the transgenic mice demonstrated Dp71 expression not only at the blood-brain barrier, where astrocytic endfeet surround the microvessels, but also at the inhibitory postsynapse of hippocampal dentate granule neurons. Interestingly, hippocampal cornu ammonis (CA)1 pyramidal neurons were negative for Dp71, although Dp427 detected by anti-dystrophin antibody was clearly present at the inhibitory postsynapse, suggesting cell-type dependent dystrophin expressions. Precise examination using the primary hippocampal culture validated exclusive localization of Dp71 at the inhibitory postsynaptic compartment but not at the excitatory synapse in neurons. We further performed interactome analysis and found that Dp71 formed distinct molecular complexes, i.e. synapse-associated Dp71 interacted with dystroglycan (Dg) and dystrobrevinβ (Dtnb), whereas glia-associated Dp71 did with Dg and dystrobrevinα (Dtna). Thus, our data indicate that Dp71 and its binding partners are relevant to the inhibitory postsynaptic function of hippocampal granule neurons and the novel Dp71-transgenic mouse provides a valuable tool to understand precise physiological expressions and functions of Dp71 and its interaction proteins in vivo and in vitro.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  DMD; Dp71; Dystrophin; Glia limitans; Inhibitory postsynapse; Transgenic mouse

Mesh:

Substances:

Year:  2022        PMID: 35098363     DOI: 10.1007/s00018-022-04151-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  44 in total

1.  Brain-related comorbidities in boys and men with Duchenne Muscular Dystrophy: A descriptive study.

Authors:  Ruben G F Hendriksen; Johan S H Vles; Marlien W Aalbers; Richard F M Chin; Jos G M Hendriksen
Journal:  Eur J Paediatr Neurol       Date:  2017-12-18       Impact factor: 3.140

2.  Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.

Authors:  Nathalie Deburgrave; Fatma Daoud; Stéphane Llense; Jean Claude Barbot; Dominique Récan; Cécile Peccate; Arthur H M Burghes; Christophe Béroud; Luis Garcia; Jean-Claude Kaplan; Jamel Chelly; France Leturcq
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

Review 3.  The neurobiology of duchenne muscular dystrophy: learning lessons from muscle?

Authors:  D J Blake; S Kröger
Journal:  Trends Neurosci       Date:  2000-03       Impact factor: 13.837

4.  Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy.

Authors:  L M Kunkel; J F Hejtmancik; C T Caskey; A Speer; A P Monaco; W Middlesworth; C A Colletti; C Bertelson; U Müller; M Bresnan; F Shapiro; U Tantravahi; J Speer; S A Latt; R Bartlett; M A Pericak-Vance; A D Roses; M W Thompson; P N Ray; R G Worton; K H Fischbeck; P Gallano; M Coulon; C Duros; J Boue; C Junien; J Chelly; G Hamard; M Jeanpierre; M Lambert; J C Kaplan; A Emery; H Dorkins; S McGlade; K E Davies; C Boehm; B Arveiler; C Lemaire; G J Morgan; M J Denton; J Amos; M Bobrow; F Benham; E Boswinkel; C Cole; V Dubowitz; K Hart; S Hodgson; L Johnson; A Walker; L Roncuzzi; A Ferlini; C Nobile; G Romeo; D E Wilcox; N A Affara; M A Ferguson-Smith; M Lindolf; H Kaariainen; A de la Chapelle; V Ionasescu; C Searby; R Ionasescu; E Bakker; G J van Ommen; P L Pearson; C R Greenberg; J L Hamerton; K Wrogemann; R A Doherty; R Polakowska; C Hyser; S Quirk; N Thomas; J F Harper; B T Darras; U Francke
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

5.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

6.  Targeted inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina.

Authors:  Cécile Dalloz; Rachel Sarig; Patrice Fort; David Yaffe; Agnès Bordais; Thomas Pannicke; Jens Grosche; Dominique Mornet; Andreas Reichenbach; José Sahel; Uri Nudel; Alvaro Rendon
Journal:  Hum Mol Genet       Date:  2003-07-01       Impact factor: 6.150

7.  Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase.

Authors:  Sylvie Tuffery-Giraud; Christophe Béroud; France Leturcq; Rabah Ben Yaou; Dalil Hamroun; Laurence Michel-Calemard; Marie-Pierre Moizard; Rafaëlle Bernard; Mireille Cossée; Pierre Boisseau; Martine Blayau; Isabelle Creveaux; Anne Guiochon-Mantel; Bérengère de Martinville; Christophe Philippe; Nicole Monnier; Eric Bieth; Philippe Khau Van Kien; François-Olivier Desmet; Véronique Humbertclaude; Jean-Claude Kaplan; Jamel Chelly; Mireille Claustres
Journal:  Hum Mutat       Date:  2009-06       Impact factor: 4.878

8.  Duchenne muscular dystrophy and epilepsy.

Authors:  M Pane; S Messina; C Bruno; A D'Amico; M Villanova; B Brancalion; S Sivo; F Bianco; P Striano; D Battaglia; D Lettori; G L Vita; E Bertini; F Gualandi; V Ricotti; A Ferlini; E Mercuri
Journal:  Neuromuscul Disord       Date:  2013-03-07       Impact factor: 4.296

9.  DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations.

Authors:  Jonas Juan-Mateu; Lidia Gonzalez-Quereda; Maria Jose Rodriguez; Manel Baena; Edgard Verdura; Andres Nascimento; Carlos Ortez; Montserrat Baiget; Pia Gallano
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

Review 10.  Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy.

Authors:  Michael Naidoo; Karen Anthony
Journal:  Mol Neurobiol       Date:  2019-12-13       Impact factor: 5.590

View more
  1 in total

1.  Dp71 Point Mutations Induce Protein Aggregation, Loss of Nuclear Lamina Integrity and Impaired Braf35 and Ibraf Function in Neuronal Cells.

Authors:  Claudia Ivette Rugerio-Martínez; Daniel Ramos; Abel Segura-Olvera; Nadia Mireya Murillo-Melo; Yessica Sarai Tapia-Guerrero; Raúl Argüello-García; Norberto Leyva-García; Oscar Hernández-Hernández; Bulmaro Cisneros; Rocío Suárez-Sánchez
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.